COVID-19-related mortality and hospital admissions in the VIVALDI study cohort: October 2020 to March 2023
Journal of Hospital Infection · 2024
DOI: 10.1016/j.jhin.2023.10.021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Hospital Infection, 2024. Verfasst von O Stirrup und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Global Health, University College London, London, UK. Electronic address: oliver.stirrup@ucl.ac.uk. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, National Institute for Health and Care Research, United Kingdom Department of Health and Social Care.
Abstract (Originalsprache)
BACKGROUND: Long-term-care facilities (LTCFs) were heavily affected by COVID-19 early in the pandemic, but the impact of the virus has reduced over time with vaccination campaigns and build-up of immunity from prior infection. OBJECTIVES: To evaluate the mortality and hospital admissions associated with SARS-CoV-2 in LTCFs in England over the course of the VIVALDI study, from October 2020 to March 2023. METHODS: We included residents aged ≥65 years from participating LTCFs who had available follow-up time within the analysis period. We calculated incidence rates (IRs) of COVID-19-linked mortality and hospital admissions per calendar quarter, along with infection fatality ratios (IFRs, within 28 days) and infection hospitalization ratios (IHRs, within 14 days) following positive SARS-CoV-2 test. RESULTS: A total of 26,286 residents were included, with at least one positive test for SARS-CoV-2 in 8513 (32.4%). The IR of COVID-19-related mortality peaked in the first quarter (Q1) of 2021 at 0.47 per 1000 person-days (1 kpd) (around a third of all deaths), in comparison with 0.10 per 1 kpd for Q1 2023 which had a similar IR of SARS-CoV-2 infections. There was a fall in observed IFR for SARS-CoV-2 infections from 24.9% to 6.7% between these periods, with a fall in IHR from 12.1% to 8.8%. The population had high overall IRs for mortality for each quarter evaluated, corresponding to annual mortality probability of 28.8-41.3%. CONCLUSIONS: Standardized real-time monitoring of hospitalization and mortality following infection in LTCFs could inform policy on the need for non-pharmaceutical interventions to prevent transmission.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute for Global Health, University College London, London, UK. Electronic address: oliver.stirrup@ucl.ac.uk.
- UCL Institute of Health Informatics, London, UK.
- UK Health Security Agency, London, UK.
- UCL Institute of Epidemiology & Healthcare, London, UK; Health Data Research UK, London, UK.
- Institute for Global Health, University College London, London, UK.
Förderung
- Wellcome Trust
- National Institute for Health and Care Research
- United Kingdom Department of Health and Social Care
Zitieren
APA
Stirrup, O., Krutikov, M., Azmi, B., Monakhov, I., Hayward, A., Copas, A., & Shallcross, L. (2024). COVID-19-related mortality and hospital admissions in the VIVALDI study cohort: October 2020 to March 2023. Journal of Hospital Infection. https://doi.org/10.1016/j.jhin.2023.10.021
Vancouver
Stirrup O, Krutikov M, Azmi B, Monakhov I, Hayward A, Copas A, et al. COVID-19-related mortality and hospital admissions in the VIVALDI study cohort: October 2020 to March 2023. Journal of Hospital Infection. 2024. doi:10.1016/j.jhin.2023.10.021
BibTeX
@article{Stirrup2024,
author = {Stirrup, O and Krutikov, M and Azmi, B and Monakhov, I and Hayward, A and Copas, A and Shallcross, L},
title = {COVID-19-related mortality and hospital admissions in the VIVALDI study cohort: October 2020 to March 2023},
journal = {Journal of Hospital Infection},
year = {2024},
doi = {10.1016/j.jhin.2023.10.021}
}
EUVIMED